- NCIt
- C35497
Loading cancer entity…
Loading cancer entity…
Clinical trials
8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07538960 | Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica. | not yet recruiting | — | 350 | Caja Costarricense de Seguro SocialOTHER_GOV | 1 | Apr 20, 2026 | clinicaltrials |
| NCT06527027 | LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes | recruiting | N/A | 1,000 | Copernicus Memorial HospitalOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT03618641 | CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease | completed | Phase 2 | 34 | Diwakar DavarOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT04553744 | Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons |
Data updated 22 days agoSource updated Apr 20, 2026source: clinicaltrials
| withdrawn |
| — |
| 0 |
| M.D. Anderson Cancer CenterOTHER |
| 0 |
| Feb 29, 2024 |
| clinicaltrials |
| NCT05287880 | Quantitative Analysis of 18F-FAPI Dynamic PET/CT for Accurate Differential Diagnosis of MLN of ESCC | unknown | — | 60 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | Mar 18, 2022 | clinicaltrials |
| NCT01815333 | Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging | completed | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02298010 | Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial | completed | — | 899 | Seoul National University HospitalOTHER | 0 | May 14, 2019 | clinicaltrials |
| NCT02555592 | Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level | unknown | — | 25 | Pusan National University HospitalOTHER | 1 | Oct 6, 2015 | clinicaltrials |